NRx Pharmaceuticals reports progress and outlook
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lotus Pharmaceutical Co Ltd (1795)
Lotus Pharmaceutical Co Ltd stock price live, this page displays TW 1795 stock exchange data. View the 1795 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lotus Pharmaceutical Co Ltd real time stock price chart below.
What Is the Lotus Pharmaceutical Co Ltd Stock Price Today?
The Lotus Pharmaceutical Co Ltd stock price today is 193.50.
What Is the Stock Symbol for Lotus Pharmaceutical Co Ltd?
The stock symbol for Lotus Pharmaceutical Co Ltd is ""1795.""
What Stock Exchange Does Lotus Pharmaceutical Co Ltd Trade On?
Lotus Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Lotus Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Lotus Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1795 quote. (ISIN: TW0001795003)
What Is the Lotus Pharmaceutical Co Ltd Stock Price Today?
The Lotus Pharmaceutical Co Ltd stock price today is 193.50.
What Is the Stock Symbol for Lotus Pharmaceutical Co Ltd?
The stock symbol for Lotus Pharmaceutical Co Ltd is ""1795.""
What Stock Exchange Does Lotus Pharmaceutical Co Ltd Trade On?
Lotus Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Lotus Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Lotus Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1795 quote. (ISIN: TW0001795003)
Taiwan
Currency in TWD
193.50
-0.50(-0.26%)
Closed·
Fair Value
An estimate of a Lotus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
192.50
195.00
52 wk Range
172.50
294.50
1795 Scorecard
Full Analysis
Management has been aggressively buying back shares
1795 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Lotus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
192.50195.00
52 wk Range
172.50294.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1795 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lotus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
322.40
Upside
+66.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Lotus Pharmaceutical Co Ltd Company Profile
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Compare 1795 to Peers and Sector
Metrics to compare | 1795 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1795PeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.5x | −56.9x | −0.5x | |
PEG Ratio | 0.50 | −1.72 | 0.00 | |
Price/Book | 2.5x | 4.4x | 2.6x | |
Price / LTM Sales | 2.7x | 2.8x | 3.3x | |
Upside (Analyst Target) | 41.1% | 0.0% | 38.7% | |
Fair Value Upside | Unlock | 27.3% | 5.0% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 322.40
(+66.61% Upside)
Earnings
Latest Release
Aug 11, 2025
EPS / Forecast
2.81 / 5.26
Revenue / Forecast
4.75B / 5.24B
FAQ
What Stock Exchange Does Lotus Pharma Trade On?
Lotus Pharma is listed and trades on the Taiwan Stock Exchange stock exchange.
What Is the Stock Symbol for Lotus Pharma?
The stock symbol for Lotus Pharma is "1795."
What Is the Lotus Pharma Market Cap?
As of today, Lotus Pharma market cap is 50.89B.
What Is Lotus Pharma's Earnings Per Share (TTM)?
The Lotus Pharma EPS (TTM) is 18.59.
When Is the Next Lotus Pharma Earnings Date?
Lotus Pharma will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is 1795 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Lotus Pharma Stock Split?
Lotus Pharma has split 7 times.
How Many Employees Does Lotus Pharma Have?
Lotus Pharma has 1099 employees.
What is the current trading status of Lotus Pharma (1795)?
As of 27 Aug 2025, Lotus Pharma (1795) is trading at a price of 193.50, with a previous close of 222.00. The stock has fluctuated within a day range of 192.50 to 195.00, while its 52-week range spans from 172.50 to 294.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.